Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Toxicities”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00090844
What this trial is testing

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerHormone ChangesDrug Toxicity
University of South Florida 49
Not applicableNot Yet RecruitingNCT07543107
What this trial is testing

Verification of Range Accuracy and Correlation With Clinical Toxicity Using Offline PET/CT for Hypofractionated Proton Radiotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Ruijin Hospital 30
Not applicableStudy completedNCT04896242
What this trial is testing

Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients

Who this might be right for
Radiotherapy; ComplicationsCardiotoxicityCancer+3 more
Pontificia Universidad Catolica de Chile 47
Testing effectiveness (Phase 2)Study completedNCT01262469
What this trial is testing

Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.

Who this might be right for
Metastatic Breast Cancer70 Years Old Patients and OverAfter One Line of Chemotherapy With Trastuzumab
UNICANCER 4
Testing effectiveness (Phase 2)Looking for participantsNCT06559540
What this trial is testing

Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer

Who this might be right for
Node-positive Breast Cancer
Washington University School of Medicine 220
Not applicableLooking for participantsNCT06387901
What this trial is testing

Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.

Who this might be right for
Breast CancerPaclitaxel Adverse ReactionChemotherapeutic Toxicity+3 more
Universitair Ziekenhuis Brussel 40
Testing effectiveness (Phase 2)Ended earlyNCT02472353
What this trial is testing

Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer

Who this might be right for
Breast CancerBreast Tumors
Avera McKennan Hospital & University Health Center 30
Not applicableLooking for participantsNCT06183268
What this trial is testing

Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma
Covenant Health Cancer Center 100
Testing effectiveness (Phase 2)UnknownNCT03167268
What this trial is testing

Panitumumab Skin Toxicity Prevention Trial

Who this might be right for
Colorectal Cancer MetastaticSkin Toxicity
Ospedale San Carlo Borromeo 28
Not applicableStudy completedNCT00875238
What this trial is testing

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Who this might be right for
Breast CancerCardiac ToxicityCardiovascular Complications
Vanderbilt University 133
Not applicableStudy completedNCT05871125
What this trial is testing

Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 39
Not applicableLooking for participantsNCT06765252
What this trial is testing

Effect of Genetic Polymorphism on Capecitabine-Induced Toxicity in Egyptian Cancer Patients

Who this might be right for
Colorectal CancerBreast Cancer
Ain Shams University 80
Large-scale testing (Phase 3)Study completedNCT00925418
What this trial is testing

Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer

Who this might be right for
Breast NeoplasmsProstate CancerNail Diseases
Institut Paoli-Calmettes 168
Not applicableStudy completedNCT00755313
What this trial is testing

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityCognitive/Functional Effects+4 more
University of California, San Francisco 81
Not applicableStudy completedNCT00806507
What this trial is testing

Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 45
Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Not applicableActive Not RecruitingNCT04166799
What this trial is testing

Randomized Phase III Trial With Mepitel Film for the Prophylaxis of Radiation Dermatitis in Breast Cancer Patients

Who this might be right for
Breast CancerRadiation Dermatitis
Sunnybrook Health Sciences Centre 216
Not applicableStudy completedNCT02725840
What this trial is testing

Breast Cancer Lung Late Effects

Who this might be right for
Radiation InjuryBreast Cancer
University of Florida 41
Not applicableLooking for participantsNCT06627595
What this trial is testing

Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management

Who this might be right for
MelanomaImmunotoxicity
University Hospital, Montpellier 160
Not applicableStudy completedNCT00922961
What this trial is testing

Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer

Who this might be right for
Breast Cancer
Centre Oscar Lambret 25
Next Page